CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
13.48
+0.37 (2.82%)
Oct 29, 2024, 4:00 PM EDT - Market closed
CervoMed Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Oct '24 Oct 29, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 111 | 43 | - | - |
| Enterprise Value | 60 | 33 | - | - |
| Last Close Price | 13.48 | 7.63 | - | - |
| PE Ratio | - | -9.35 | - | - |
| PS Ratio | 8.55 | 6.06 | - | - |
| PB Ratio | 2.23 | 5.87 | - | - |
| P/FCF Ratio | -18.52 | -5.81 | - | - |
| P/OCF Ratio | -18.52 | -5.81 | - | - |
| EV/Sales Ratio | 6.25 | 4.60 | - | - |
| EV/EBIT Ratio | -13.57 | -4.69 | - | - |
| EV/FCF Ratio | -17.68 | -4.41 | - | - |
| Debt / Equity Ratio | - | - | -1.38 | -2.74 |
| Debt / FCF Ratio | - | - | -4.83 | -2.42 |
| Asset Turnover | - | 1.01 | - | - |
| Quick Ratio | 14.03 | 3.35 | 0.31 | 1.48 |
| Current Ratio | 14.73 | 3.84 | 0.32 | 1.50 |
| Return on Assets (ROA) | - | -62.04% | -39.59% | - |
| Return on Capital (ROIC) | - | -81.22% | -44.40% | - |
| Earnings Yield | -4.53% | -5.02% | - | - |
| FCF Yield | -6.86% | -17.21% | - | - |
| Buyback Yield / Dilution | -35.96% | -413.65% | 88.49% | - |
| Total Shareholder Return | -35.96% | -413.65% | 88.49% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.